{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:26:08Z","timestamp":1758893168290},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,5]]},"DOI":"10.7759\/cureus.32197","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T10:03:21Z","timestamp":1670234601000},"source":"Crossref","is-referenced-by-count":1,"title":["Predictors of the Need to Use Medications in the Management of Neonatal Hypoglycemia"],"prefix":"10.7759","author":[{"given":"Samira","family":"Al Hosni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija","family":"Al Ghaithi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathiya","family":"P. Murthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussain","family":"Alsaffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilal","family":"Al Mandhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1179556517748913","article-title":"Hypoglycemia: when to treat?","volume":"11","author":"Kallem VR","year":"2017","unstructured":"Kallem VR, Pandita A, Gupta G. Hypoglycemia: when to treat?. Clin Med Insights Pediatr. 2017, 11:3-7. 10.1177\/1179556517748913","journal-title":"Clin Med Insights Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14744\/SEMB.2019.08634","article-title":"Risk factor assessment and the incidence of neonatal hypoglycemia in the postnatal period","volume":"53","author":"B\u00fclb\u00fcl A","year":"2019","unstructured":"B\u00fclb\u00fcl A, Bahar S, Uslu S, S\u00f6zeri \u015e, B\u00fclb\u00fcl L, Ba\u015f EK, \u00dcnal ET. Risk factor assessment and the incidence of neonatal hypoglycemia in the postnatal period. Sisli Etfal Hastan Tip Bul. 2019, 53:389-94. 10.14744\/SEMB.2019.08634","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2017.11.009","article-title":"Incidence of hypoglycemia in newborns at risk and an audit of the 2011 American academy of pediatrics guideline for hypoglycemia","volume":"59","author":"Hosagasi NH","year":"2018","unstructured":"Hosagasi NH, Aydin M, Zenciroglu A, Ustun N, Beken S. Incidence of hypoglycemia in newborns at risk and an audit of the 2011 American academy of pediatrics guideline for hypoglycemia. Pediatr Neonatol. 2018, 59:368-74. 10.1016\/j.pedneo.2017.11.009","journal-title":"Pediatr Neonatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2016.08.007","article-title":"Neonatal hypoglycemia","volume":"22","author":"Adamkin DH","year":"2017","unstructured":"Adamkin DH. Neonatal hypoglycemia. Semin Fetal Neonatal Med. 2017, 22:36-41. 10.1016\/j.siny.2016.08.007","journal-title":"Semin Fetal Neonatal Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-013-1135-3","article-title":"Neonatal hypoglycemia","volume":"81","author":"Arya VB","year":"2014","unstructured":"Arya VB, Senniappan S, Guemes M, Hussain K. Neonatal hypoglycemia. Indian J Pediatr. 2014, 81:58-65. 10.1007\/s12098-013-1135-3","journal-title":"Indian J Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/fn.83.2.f117","article-title":"Blood glucose levels in a population of healthy, breast fed, term infants of appropriate size for gestational age","volume":"83","author":"Hoseth E","year":"2000","unstructured":"Hoseth E, Joergensen A, Ebbesen F, Moeller M. Blood glucose levels in a population of healthy, breast fed, term infants of appropriate size for gestational age. Arch Dis Child Fetal Neonatal Ed. 2000, 83:F117-9. 10.1136\/fn.83.2.f117","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.5.1141","article-title":"Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds","volume":"105","author":"Cornblath M","year":"2000","unstructured":"Cornblath M, Hawdon JM, Williams AF, Aynsley-Green A, Ward-Platt MP, Schwartz R, Kalhan SC. Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics. 2000, 105:1141-5. 10.1542\/peds.105.5.1141","journal-title":"Pediatrics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.03.057","article-title":"Recommendations from the Pediatric Endocrine Society for evaluation and management of persistent hypoglycemia in neonates, infants, and children","volume":"167","author":"Thornton PS","year":"2015","unstructured":"Thornton PS, Stanley CA, De Leon DD, et al.. Recommendations from the Pediatric Endocrine Society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J Pediatr. 2015, 167:238-45. 10.1016\/j.jpeds.2015.03.057","journal-title":"J Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.02.045","article-title":"Re-evaluating \"transitional neonatal hypoglycemia\": mechanism and implications for management","volume":"166","author":"Stanley CA","year":"2015","unstructured":"Stanley CA, Rozance PJ, Thornton PS, et al.. Re-evaluating \"transitional neonatal hypoglycemia\": mechanism and implications for management. J Pediatr. 2015, 166:1520-5. 10.1016\/j.jpeds.2015.02.045","journal-title":"J Pediatr"},{"key":"ref10","article-title":"Glucose","author":"Volpe JJ","year":"2017","unstructured":"Volpe JJ, Inder T, Darras B, de Vries L, du Plessis A, Neil J, Perlman J. Glucose. Volpe's Neurology of the Newborn. Elsevier, Amsterdam, Netherlands; 2017. 6:718-25."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7177.194a","article-title":"Outcome of neonatal hypoglycaemia. Complete data are needed","volume":"318","author":"Cornblath M","year":"1999","unstructured":"Cornblath M, Schwartz R. Outcome of neonatal hypoglycaemia. Complete data are needed. BMJ. 1999, 318:194-5. 10.1136\/bmj.318.7177.194a","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/RRN.S55353","article-title":"Current perspectives on neonatal hypoglycemia, its management, and cerebral injury risk","volume":"5","author":"Chandran S","year":"2015","unstructured":"Chandran S, Rajadurai V, Alim A, Hussain K. Current perspectives on neonatal hypoglycemia, its management, and cerebral injury risk. Res Rep Neonatol. 2015, 5:17-30. 10.2147\/RRN.S55353","journal-title":"Res Rep Neonatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(05)80969-2","article-title":"Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism","volume":"123","author":"Thornton PS","year":"1993","unstructured":"Thornton PS, Alter CA, Katz LE, Baker L, Stanley CA. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism. J Pediatr. 1993, 123:637-43. 10.1016\/s0022-3476(05)80969-2","journal-title":"J Pediatr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1866","article-title":"Long-term follow-up of children with congenital hyperinsulinism on octreotide therapy","volume":"99","author":"Demirbilek H","year":"2014","unstructured":"Demirbilek H, Shah P, Arya VB, Hinchey L, Flanagan SE, Ellard S, Hussain K. Long-term follow-up of children with congenital hyperinsulinism on octreotide therapy. J Clin Endocrinol Metab. 2014, 99:3660-7. 10.1210\/jc.2014-1866","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.1999.12.6.873","article-title":"Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycemia of infancy","volume":"12","author":"Ba\u015f F","year":"1999","unstructured":"Ba\u015f F, Darendeliler F, Demirkol D, Bundak R, Saka N, G\u00fcn\u00f6z H. Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycemia of infancy. J Pediatr Endocrinol Metab. 1999, 12:873-8. 10.1515\/jpem.1999.12.6.873","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310967","article-title":"Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia","volume":"370","author":"Senniappan S","year":"2014","unstructured":"Senniappan S, Alexandrescu S, Tatevian N, et al.. Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia. N Engl J Med. 2014, 370:1131-7. 10.1056\/NEJMoa1310967","journal-title":"N Engl J Med"},{"key":"ref17","unstructured":"National Library of Medicine. Dailey Med. Package insert. Proglycem-diazoxide suspension. (2015). Accessed: October 17, 2021: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=b16c7832-2fd9-49af-b923-1dc0d91fd6e2."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1515\/crpm-2013-0024","article-title":"Diazoxide treatment for persistent hypoglycemia in a small for gestational age preterm infant with adequate low insulin levels","volume":"3","author":"Arnon S","year":"2014","unstructured":"Arnon S, Lagerev E, Herzlich J, Eliakim A, Litmanovitz I. Diazoxide treatment for persistent hypoglycemia in a small for gestational age preterm infant with adequate low insulin levels. Case Rep Perinat Med. 2014, 3:83-5. 10.1515\/crpm-2013-0024","journal-title":"Case Rep Perinat Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa543","article-title":"Management and appropriate use of diazoxide in infants and children with hyperinsulinism","volume":"105","author":"Brar PC","year":"2020","unstructured":"Brar PC, Heksch R, Cossen K, et al.. Management and appropriate use of diazoxide in infants and children with hyperinsulinism. J Clin Endocrinol Metab. 2020, 105:1-5. 10.1210\/clinem\/dgaa543","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/20420986211011338","article-title":"The danger of diazoxide in the neonatal intensive care unit","volume":"12","author":"Desai J","year":"2021","unstructured":"Desai J, Key L, Swindall A, Gaston K, Talati AJ. The danger of diazoxide in the neonatal intensive care unit. Ther Adv Drug Saf. 2021, 12:3-7. 10.1177\/20420986211011338","journal-title":"Ther Adv Drug Saf"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000520512","article-title":"Evaluation of risk factors and approach to screening for asymptomatic neonatal hypoglycemia","volume":"119","author":"Cummings CT","year":"2022","unstructured":"Cummings CT, Ritter V, LeBlanc S, Sutton AG. Evaluation of risk factors and approach to screening for asymptomatic neonatal hypoglycemia. Neonatology. 2022, 119:77-83. 10.1159\/000520512","journal-title":"Neonatology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2017.1391781","article-title":"Early neonatal hypoglycemia: incidence of and risk factors. A cohort study using universal point of care screening","volume":"32","author":"Bromiker R","year":"2019","unstructured":"Bromiker R, Perry A, Kasirer Y, Einav S, Klinger G, Levy-Khademi F. Early neonatal hypoglycemia: incidence of and risk factors. A cohort study using universal point of care screening. J Matern Fetal Neonatal Med. 2019, 32:786-92. 10.1080\/14767058.2017.1391781","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2012.05.022","article-title":"Incidence of neonatal hypoglycemia in babies identified as at risk","volume":"161","author":"Harris DL","year":"2012","unstructured":"Harris DL, Weston PJ, Harding JE. Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr. 2012, 161:787-91. 10.1016\/j.jpeds.2012.05.022","journal-title":"J Pediatr"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.00034","article-title":"Incidence and risk factors for hypoglycemia during fetal-to-neonatal transition in premature infants","volume":"8","author":"Mitchell NA","year":"2020","unstructured":"Mitchell NA, Grimbly C, Rosolowsky ET, O'Reilly M, Yaskina M, Cheung PY, Schm\u00f6lzer GM. Incidence and risk factors for hypoglycemia during fetal-to-neonatal transition in premature infants. Front Pediatr. 2020, 8:34. 10.3389\/fped.2020.00034","journal-title":"Front Pediatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1515\/prilozi-2017-0013","article-title":"Neonatal hypoglycemia: risk factors and outcomes","volume":"38","author":"Stomnaroska O","year":"2017","unstructured":"Stomnaroska O, Petkovska E, Jancevska S, Danilovski D. Neonatal hypoglycemia: risk factors and outcomes. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017, 38:97-101. 10.1515\/prilozi-2017-0013","journal-title":"Pril (Makedon Akad Nauk Umet Odd Med Nauki)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-019-0404-z","article-title":"Maternal obesity and cesarean section delivery: additional risk factors for neonatal hypoglycemia?","volume":"39","author":"Turner D","year":"2019","unstructured":"Turner D, Month\u00e9-Dr\u00e8ze C, Cherkerzian S, Gregory K, Sen S. Maternal obesity and cesarean section delivery: additional risk factors for neonatal hypoglycemia?. J Perinatol. 2019, 39:1057-64. 10.1038\/s41372-019-0404-z","journal-title":"J Perinatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2014.918599","article-title":"Hypoglycemia incidence and risk factors assessment in hospitalized neonates","volume":"28","author":"Zhou W","year":"2015","unstructured":"Zhou W, Yu J, Wu Y, Zhang H. Hypoglycemia incidence and risk factors assessment in hospitalized neonates. J Matern Fetal Neonatal Med. 2015, 28:422-5. 10.3109\/14767058.2014.918599","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/124786-predictors-of-the-need-to-use-medications-in-the-management-of-neonatal-hypoglycemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:33Z","timestamp":1707507873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/124786-predictors-of-the-need-to-use-medications-in-the-management-of-neonatal-hypoglycemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.32197","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,5]]}}}